Published: March 7, 2019

Introduction {#sec1}
============

Autophagy is critical for the bulk degradation of various intracellular components and for cellular homeostasis ([@bib12], [@bib36]). Moreover, autophagosomes can be built around specific subcellular components destined for selective degradation ([@bib19]). Selective autophagic targets, such as damaged mitochondria or invading bacteria, first become tagged by ubiquitin, which serves as an "eat me" signal. Then autophagy receptors bind ubiquitinated cargo via their ubiquitin binding domains ([@bib43], [@bib5], [@bib31]). Autophagy-related (ATG) proteins then assemble to facilitate the formation of early double-membrane structures called isolation membranes that expand around the cargo. Once fully encapsulating cargo, the autophagosome fuses with lysosomes for content degradation ([@bib50], [@bib7]). The orchestrated steps of autophagosome formation, involving many ATG proteins, have been elucidated ([@bib6], [@bib24]). However, there is no clear mechanism known to link cargo recognition with autophagosome biogenesis in mammals, and it is uncertain what provides the targeting mechanism to nucleate the early autophagy machinery in the vicinity of organelles destined for degradation. 

The prevailing model for selective autophagy posits that autophagy receptors, such as NDP52, bridge ubiquitinated cargos through their ubiquitin binding domains with preformed, expanding autophagosomes studded with lipidated LC3 via their LC3-interacting regions ([@bib31], [@bib8]). However, recent studies exploring the role of LC3/GABARAP family proteins during mitophagy found that autophagosomes can still selectively form around cargo in the absence of all LC3/GABARAP proteins ([@bib38], [@bib42]). Instead, these studies found that LC3/GABARAP proteins are important for lysosomal fusion steps. Consistently, early ATG proteins are recruited to mitochondria during CCCP-induced mitophagy even in cells lacking ATG3, an E2-like enzyme critical for LC3-PE conjugation ([@bib25]). Thus, the function of autophagy receptors in relation to LC3 and autophagosome recruitment to cargo is unclear. We previously demonstrated that CRISPR KO cell lines lacking all known sequestosome-like autophagy receptors have a defect in ULK1 complex recruitment and mitophagy ([@bib34]), which suggests a role for autophagy receptors in initiating this first step in isolation membrane formation directly on the cargo. Therefore, autophagy receptors, such as NDP52, OPTN, and Tax1bp1, could potentially be the missing link between cargo recognition and the spatiotemporal initiation of autophagosome biogenesis.

The ULK1 complex, the most upstream machinery during autophagosome biogenesis, consists of ULK1 kinase, FIP200, ATG13, and ATG101 ([@bib36]). During starvation-induced non-selective autophagy, AMPK kinase is activated by loss of nutrient availability, which in turn activates ULK1 to initiate clearance of intracellular contents ([@bib30], [@bib18]). Although AMPK activation has been linked to mitochondrial dynamics ([@bib52]) and to mitochondrial biogenesis ([@bib26], [@bib10]), it is less clear whether AMPK is involved in PINK1/Parkin-dependent mitophagy or other modes of selective autophagy ([@bib22]). Conversely, when cells are nutrient replete, mTOR kinase phosphorylates ULK1 to constitutively inhibit autophagy ([@bib30]). How ULK1 overcomes mTOR inhibition during fed states to initiate selective degradation of various cargo is unknown. Studies on Atg1, the yeast homolog of ULK1, demonstrated that Atg1 autoactivates on cargo by local clustering ([@bib51], [@bib28]). Researchers investigating ULK1 activation induce autophagy by globally depleting cellular energy and nutrient availability ([@bib2], [@bib45]). Such widespread alteration in energetic states leading to ULK1 activation may not recapitulate the function of ULK1 during selective autophagy ([@bib40]), during which bioenergetic states can be normal. Thus, it is unclear how ULK1 is activated during selective autophagy.

Another multifunctional kinase implicated in selective autophagy is TANK-Binding Kinase1 (TBK1). Recent reports have shown that TBK1 phosphorylates autophagy receptors, which affects their affinity toward ubiquitin chains on damaged cargo, as well as LC3-II ([@bib57], [@bib37], [@bib21], [@bib44]). Furthermore, TBK1 aids in the initiation of bacterial autophagy ([@bib49]) and mediates signaling crosstalk between energy-sensing and inflammatory pathways through AMPK ([@bib60]), indicating that TBK1 controls multiple aspects of autophagy.

In this study, we delineate the mechanism for the initiation of selective autophagy. We find that NDP52 and TBK1 cooperate to recruit the ULK1 complex to ubiquitinated cargo, leading to ULK1 kinase activation, which occurs independently of energy-sensing pathways.

Results {#sec2}
=======

NDP52-Mediated Mitophagy by Chemically Inducible Protein Localization {#sec2.1}
---------------------------------------------------------------------

During depolarization-induced mitophagy, NDP52 and a number of other autophagy-related proteins are recruited to the mitochondria. To isolate the role of NDP52 in autophagosome biogenesis, we used chemically induced dimerization (CID) assays to directly recruit NDP52 to mitochondria without perturbing cell metabolism ([Figure 1](#fig1){ref-type="fig"}A). We stably expressed FKBP-GFP-NDP52 and FRB-Fis1 in cells also expressing mito-mKeima to quantify mitophagic flux ([@bib34], [@bib46]). Localizing NDP52 to the mitochondria with a compound that induces the dimerization of FKBP and FRB results in the appearance of mitolysosomes detected by imaging ([Figure 1](#fig1){ref-type="fig"}B) and by FACS analysis ([Figure 1](#fig1){ref-type="fig"}C). The mitolysosomes observed are not due to Parkin-mediated mitophagy, since HeLa cells do not express endogenous Parkin ([@bib9]). We also localized NDP52 to mitochondria in PINK1 KO cells and found no difference from WT cells in mitolysosome formation ([Figure 1](#fig1){ref-type="fig"}D). Thus, ectopic recruitment of NDP52 can induce mitophagy independently or downstream of the PINK1/Parkin pathway. Consistently, forced mitochondrial localization of NDP52 results in the recruitment of the ATG proteins: FIP200, ATG14, and ATG16L1 ([Figures 1](#fig1){ref-type="fig"}E--1G; quantified in [Figures 1](#fig1){ref-type="fig"}H--1J). ATG14 and ATG16L1 are downstream of FIP200 and involved in phagophore maturation ([@bib56]). Together, these results indicate that targeting of NDP52 to cargo is sufficient to mobilize ATG proteins to initiate selective cargo degradation.Figure 1Ectopic Recruitment of NDP52 to Mitochondria Can Initiate Mitophagy by Recruiting ATG Machinery(A) Schematic of chemically inducible dimerization assay to control mitochondrial localization of NDP52.(B) Live confocal imaging of HeLa cells stably expressing mito-mKeima and FRB-Fis1 and transiently expressing FKBP-GFP-NDP52. Cells were treated with Rapalog for 24 h. Cytosolic mitochondria (488 nm; red) and mitolysosomes (561 nm; purple) are shown.(C) FACS plots showing mito-mKeima ratio (561/488 nm). HeLa cells stably expressing mito-mKeima, FRB-Fis1, and FKBP-GFP-NDP52 were treated with Rapalog for 24 h.(D) Quantification of mito-mKeima ratiometric FACS analysis of WT or PINK1 KO HeLa cells stably expressing mito-mKeima, FRB-Fis1, and FKBP-GFP-NDP52 after 24 h of Rapalog treatment. n = 3 biological replicates.(E--G) Confocal images of HeLa cells stably expressing mito-mKeima, FRB-Fis1, and FKBP-GFP-NDP52. Cells were transfected with (E) HA-FIP200, (F) HA-ATG14, and (G) Flag-ATG16L1. Cells were then treated with Rapalog for 24 h, fixed, then immunostained for Tom20 with either HA or Flag.(H) Quantification of FIP200 recruitment to mitochondria by Pearson's correlation coefficient as in (E).(I) Quantification of ATG14 recruitment to mitochondria by Pearson's correlation coefficient as in (F).(J) Quantification of the number of ATG16L1 foci on mitochondria before and after Rapalog treatment as in (G). Arrows indicate foci of ATG16L1 colocalized with Tom20.All FACS quantifications: n = 3. Data are represented as mean ± SD. p value: ^∗^ = \< 0.05; ^∗∗^ \< 0.01; ^∗∗∗^ \< 0.001; ^∗∗∗∗^ \< 0.00001; ns., not significant. Scale bars: 10 μm.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

NDP52 Interacts with the ULK1 Complex through FIP200 {#sec2.2}
----------------------------------------------------

That NDP52 can directly initiate mitophagy and recruit various ATG proteins when experimentally localized to mitochondria suggests that NDP52 may be interacting with the autophagy machinery. Consistent with this notion, a previous unbiased yeast two-hybrid screen revealed an interaction between FIP200 and NDP52 ([@bib55]). Immunoprecipitation experiments with either ULK1 or FIP200 revealed that endogenous NDP52 associates with the endogenous ULK1 complex: ULK1 kinase, ATG13, and FIP200 ([Figures 2](#fig2){ref-type="fig"}A and 2B). Moreover, the association of NDP52 to the ULK1 complex is enhanced during Parkin-mediated mitophagy ([Figures 2](#fig2){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}A). At endogenous NDP52 levels, the increase in the interaction of NDP52 and the ULK1 complex during mitophagy requires DSP crosslinking for clear detection. ATG14, a component of the VPS34 complex, does not appear to interact with NDP52 even under crosslinking conditions, suggesting some specificity of the association of NDP52 to the ULK1 complex ([Figure 2](#fig2){ref-type="fig"}C). In FIP200 KO cells, NDP52 no longer associates with ULK1, suggesting that NDP52 binds the complex through FIP200 ([Figure 2](#fig2){ref-type="fig"}D). This binding deficiency occurs even though FIP200 KO cells have much higher NDP52 protein levels ([Figures 2](#fig2){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}B). These interactions were confirmed by complementary immunoprecipitation of ULK1 in WT or FIP200 KO cells ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Co-overexpression of FIP200 increased the association of exogenous NDP52 with ULK1 ([Figure S1](#mmc1){ref-type="supplementary-material"}D).Figure 2NDP52 Interacts with ULK1 Complex through FIP200(A and B) Western analysis of immunoprecipitation assay of endogenous FIP200 (B) or ULK1 (A) in HeLa cells.(C) Endogenous immunoprecipitation of NDP52 from WT HeLa cells treated with oligomycin/antimycin (OA) and Bafilomycin (200 nM; to prevent receptor degradation) for 3 h. Cells were crosslinked *in situ* using DSP prior to immunoprecipitation and western blot analysis.(D) Western analysis of immunoprecipitation assay for NDP52 in either WT or FIP200 KO HeLa cells.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Functional Analysis of NDP52-FIP200 Interaction {#sec2.3}
-----------------------------------------------

To corroborate the interaction of NDP52 and FIP200, we performed mutational mapping ([Figure 3](#fig3){ref-type="fig"}A). NDP52 contains 7 distinct domains ([@bib58], [@bib53]). The deletion of the SKICH domain of NDP52, which is responsible for interactions with Nap1 and Sintbad ([@bib48]), inhibited the NDP52-FIP200 association ([Figure 3](#fig3){ref-type="fig"}B). In contrast, mutations in the LIR domains of NDP52 did not attenuate interaction with FIP200 (CLIR/LIR-like null; [Figures 3](#fig3){ref-type="fig"}B and 3C). Using the FIP200-binding-deficient NDP52 mutant, we tested the importance of the SKICH domain for NDP52-CID-mediated mitophagy. FIP200 was not recruited to the mitochondria when the CID assay was performed using FKBP-ΔSKICH-NDP52 ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Furthermore, we did not detect mitophagy after localizing a FKBP-ΔSKICH-NDP52 mutant to mitochondria, suggesting that the interaction of NDP52 with FIP200 is critical for the ability of NDP52 to initiate mitophagy ([Figure 4](#fig4){ref-type="fig"}A). Thus, the binding of NDP52 to FIP200 through the SKICH domain appears to be important for mitophagy induced by NDP52 cargo localization.Figure 3Mutational Dissection of NDP52-FIP200 Interaction(A) Diagram of NDP52 mutation and deletions. ΔSKICH is a deletion from position 1--127. ΔSKICH ΔCLIR is a deletion from 1--148. CLIR null is a V136S mutation in the LC3C binding domain. LIR-like null pertains to AAAA substitution of DYWE at position 203--206 within the non-canonical LIR domain. C425A is a mutation in ubiquitin-binding ZF2 motif. Diagram of FIP200 mutations and deletions. Q4A refers to 4 alanine substitutions within the ATG13-binding domain. LZA refers to 4 alanine mutations in the leucine zipper domain.(B) Western analysis of Flag-NDP52 WT and mutants (see [Figure 3](#fig3){ref-type="fig"}H for NDP52 mutation map), and HA-FIP200 were transiently transfected in HEK293T cells followed by HA immunoprecipitation.(C) Western analysis of HA-FIP200 immunoprecipitation performed on HEK293T cells overexpressing HA-FIP200 and GFP-NDP52 or GFP-NDP52 CLIR/LIR-like null. Arrow indicates NDP52 band. Asterisks indicate background bands.(D) Western blot analysis of HEK293T cells transfected with full-length, N1 (1--800), and C1 (800--1,591) HA-FIP200 co-transfected with Flag-NDP52, then subjected to HA immunoprecipitation.(E) Western blot analysis after HA immunoprecipitation performed in HEK293T cells transfected with HA-FIP200 C1 (800--1,591), C2 (1,300--1,591), C3 (1,400--1,591) and Flag-NDP52.(F) Western blot analysis after HA immunoprecipitation performed on HEK293T cells transfected with HA-LZ (1,286--1,413 of FIP200), HA-LZA (1,286--1,413 of FIP200; AAAA substitution at positions 1,371, 1,378, 1,385, and 1,392) and Flag-NDP52.(G) Western blot analysis after HA immunoprecipitation performed on HEK293T cells transfected with full-length HA-FIP200, HA-FIP200 Q4A (full-length FIP200 with AAAA substitutions at positions 582--585), HA-FIP200 LZA (full-length FIP200 with AAAA substitution at positions 1,371, 1,378, 1,385, 1,392), and Flag-NDP52.(H) Confocal imaging of WT HeLa cells stably expressing mCherry-Parkin and GFP-NDP52 and transiently transfected with WT FIP200 leucine zipper (HA-LZ) or alanine mutant (HA-LZA), then treated with OA for 3 h. Cells were then fixed and stained for HA. Scale bars: 10 μm.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.Figure 4NDP52 Mediates Autophagosome Biogenesis on Cargo Organelle Independent of LC3(A and B) Quantification of FACS ratiometric analysis of mito-mKeima after 24 h treatment of Rapalog. HeLa cells stably expressing FRB-Fis1, mito-mKeima, and FKBP-GFP-NDP52 WT and ΔSKICH in (A) or FKBP-GFP-NDP52 CLIR/LIR-like null in (B).(C) Quantification of DFCP1 foci. WT or 6KO (LC3/GABARAP hexa KO) cells expressing GFP-DFCP1 were analyzed at basal conditions or after 3 h OA.(D) Confocal imaging of WT or 6KO HeLa cells transiently expressing GFP-ULK1, GFP-FIP200, or GFP-DFCP1, as well as HA-Parkin. Cells were immunostained for HA.(E--G) Pearson's correlation or automated counting of overlapping puncta between FIP200 (E), ULK1 (F), or DFCP1 (G) on Parkin before or after OA treatment.(H and I) Quantification of FACS ratiometric analysis of mito-mKeima. FKBP-GFP-ULK1 (I) or NDP52 (H) were stably expressed with FRB-Fis1 and mito-mKeima in WT or 6KO cells. Cells were then treated with Rapalog for 24 h.(J) NDP52 WT and mutants, as well as mito-mKeima, were stably expressed in OPTN, NDP52, Tax1bp1 triple KO cells (TKO). Cells were treated with OA for 6 h then analyzed by FACS for mitophagy.All FACS quantifications: n = 3. Data are represented as mean ± SD. p value: ^∗^ = \< 0.05; ^∗∗^ \< 0.01; ^∗∗∗^ \< 0.001; ^∗∗∗∗^ \< 0.00001; ns., not significant. Scale bars: 10 μm.See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

FIP200 is important for the integrity of the ULK1 complex by acting as a scaffold for its components ([@bib23]). Comparing FIP200 truncation mutants revealed that only the C-terminal half of FIP200 has affinity for NDP52 (FIP200 C1: 800--1,591 aa; [Figure 3](#fig3){ref-type="fig"}D). A peptide containing the C-terminal leucine zipper domain of FIP200 is sufficient to co-precipitate NDP52 (FIP200 C2: 1,300--1,591 aa), whereas a C-terminal fragment excluding the leucine zipper domain is defective in binding NDP52 (FIP200 C3: 1,400--1,591 aa; [Figure 3](#fig3){ref-type="fig"}E). Further truncation of FIP200 revealed that a 127-aa peptide spanning the leucine zipper domain (LZ; 1,286--1,413 aa) is sufficient to interact with NDP52. Mutating the 4 leucines to alanines (LZA; L1371A, L1378A, L1392A, and L1385A) in the leucine zipper peptide abolishes this association ([Figure 3](#fig3){ref-type="fig"}F). Importantly, mutating the same 4 leucines to alanines within the leucine zipper of the full-length FIP200 also attenuates its binding to NDP52 ([Figure 3](#fig3){ref-type="fig"}G). A previous report showed that four contiguous point mutations in FIP200 at positions 582--585 from LFQL to AAAA selectively eliminated the starvation-induced autophagic function of FIP200 by preventing the interaction between FIP200 and ATG13 ([@bib11]). We found that these mutations have no effect on the association of FIP200 and NDP52, suggesting that the interaction of FIP200 and NDP52 may be dissociable from the association of FIP200 with the ULK1 complex ([Figure 3](#fig3){ref-type="fig"}G). To validate the involvement of the leucine zipper domain of FIP200 in interacting with NDP52 in live cells, we expressed the WT leucine zipper (LZ: 1,286--1,413 aa) or the alanine mutant leucine zipper (LZA: 1,286--1,413 aa; L1371A, L1378A, L1392A, and L1385A) in cells stably expressing Parkin and NDP52. The leucine zipper peptide translocated with NDP52 to Parkin foci after Oligomycin and Antimycin (OA) treatment, whereas the 4-alanine mutant peptide did not ([Figure 3](#fig3){ref-type="fig"}H). Thus, FIP200 interacts with NDP52 through its leucine zipper domain.

NDP52 Mediates *De Novo* LC3-Independent Selective Autophagy {#sec2.4}
------------------------------------------------------------

Ablation of the SKICH domain hinders NDP52-CID-induced mitophagy ([Figure 4](#fig4){ref-type="fig"}A). ΔSKICH NDP52 still interacts with LC3/GABARAP proteins ([@bib54], [@bib53]), suggesting that the interaction of NDP52 with LC3/GABARAPs may not be necessary for NDP52-mediated mitophagosome biogenesis. NDP52 binds ubiquitin chains through the ZF2 domain ([@bib48]), and only the ZF2 domain is absolutely required for the recruitment of NDP52 to mitochondria after OA treatment, while SKICH or LC3-binding domains are not ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Consistently, only the ablation of the ZF2 domain of NDP52, but not SKICH or CLIR, blocked the ubiquitin binding of NDP52 ([Figure S2](#mmc1){ref-type="supplementary-material"}E). These results show that the ubiquitin binding of NDP52 through ZF2 dictates its recruitment to cargo during Parkin-induced mitophagy, while the SKICH domain of NDP52 allows it to associate with the ULK1 complex ([Figure 3](#fig3){ref-type="fig"}B).

To directly test the importance of the LC3 binding of NDP52, we directed CLIR/LIR-like mutant NDP52 to the mitochondria using CID. This mutant induces mitophagy as efficiently as WT NDP52 ([Figure 4](#fig4){ref-type="fig"}B). Furthermore, upstream ATG proteins such as FIP200 and ULK1, as well as PI3P-binding protein DFCP1, are all able to localize to Parkin foci after inducing mitophagy with OA even in cells lacking all LC3/GABARAP proteins ([Figure 4](#fig4){ref-type="fig"}D; quantified in [Figures 4](#fig4){ref-type="fig"}E--4G). However, no mitolysosomes were observed after recruiting NDP52 or ULK1 to mitochondria of LC3/GABARAP KO cells, suggesting an inhibition of autophagosome-lysosome fusion events in the absence of LC3 proteins ([Figures 4](#fig4){ref-type="fig"}H and 4I). This interpretation is corroborated by the accumulation of DFCP1 foci in LC3/GABARAP KO cells at basal states ([Figure 4](#fig4){ref-type="fig"}C). Importantly, the block in Parkin-dependent mitophagy in OPTN, NDP52, and Tax1bp1 TKO cells can be rescued by complementation of either WT or LC3-binding-deficient NDP52 ([Figure 4](#fig4){ref-type="fig"}J). These data are consistent with previous findings showing that LC3/GABARAP proteins are not necessary for autophagosome targeting but rather in later autophagosome-lysosome fusion events ([@bib38]). Furthermore, these results suggest that the capacity of NDP52 to bind LC3 proteins is not required for its function in localizing the ULK1 complex to mediate selective degradation of ubiquitinated cargo.

Synthetic FIP200-Binding Peptide Induces Selective Autophagy {#sec2.5}
------------------------------------------------------------

If the localization of the ULK1 complex to specific cargo by NDP52 can initiate *de novo* autophagosome biogenesis, then other proteins capable of binding FIP200 may also induce mitophagy when artificially targeted to the mitochondria. ATG16L1 interacts with FIP200 ([@bib13], [@bib17], [@bib39]) and is part of the Atg12-Atg5 ubiquitin-like conjugation system important for the recruitment of LC3 to the phagophore. We generated a truncated ATG16L1 peptide (100--250 aa) containing only the FIP200-binding region fused to FKBP ([Figure S3](#mmc1){ref-type="supplementary-material"}A), thus excluding the LC3-dependent roles of ATG16L1 from our analyses. Localizing the ATG16L1 peptide to the mitochondria induced mitophagy ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Indeed, introducing E230R/E241R mutations into the ATG16L1 peptide, which abrogated the interaction with FIP200 ([Figure S3](#mmc1){ref-type="supplementary-material"}C; [@bib13]), prevented the induction of mitophagy ([Figure S3](#mmc1){ref-type="supplementary-material"}B). These experiments using a synthetic FIP200-binding peptide confirm that localizing the ULK1 complex to cargo initiates selective autophagy.

Ectopic Localization of ULK1 on Cargo Drives Induction of Selective Autophagy Independent of Energy-Sensing Pathways {#sec2.6}
--------------------------------------------------------------------------------------------------------------------

It was previously reported that ULK1 is activated by AMPK during mitophagy ([@bib14]). Monitoring mitophagy in AMPK alpha 1/2 double-KO cells (AMPK DKO) after OA treatment revealed that these cells had no defect in PINK1/Parkin-mediated mitophagy by western blot or mito-mKeima FACS analysis ([Figures 5](#fig5){ref-type="fig"}A and 5B). Furthermore, 4 or 18 h of starvation did not induce mitophagy in either WT or AMPK DKO cells ([Figures 5](#fig5){ref-type="fig"}A and 5C). On the other hand, pharmacologic inhibition of ULK1/2 kinase fully inhibited OA-induced mitophagy, confirming that ULK1/2 kinase activity is required for PINK1/Parkin-mediated mitophagy ([Figure 5](#fig5){ref-type="fig"}D). Interestingly, unlike FIP200 KO cells, which displayed defective LC3 lipidation as well as aberrant p62 accumulation, the AMPK DKO U2OS cells had LC3 lipidation defects yet did not accumulate p62 basally ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4D). Starvation or Torin1 treatment of these AMPK DKO cells resulted in the degradation of p62, which was recovered by co-treatment with Bafilomycin. This observation is in contrast to loss of AMPK in mouse, where basal accumulation of p62 is observed ([@bib14]).Figure 5ULK1 Autoactivation by Ectopic Localization Elicits Mitophagy(A) WT or AMPK DKO U2OS cells stably expressing YFP-Parkin were either treated with OA or starved in HBSS for 18 h followed by western blot analysis of mitochondrial proteins to measure mitophagy.(B) Cells in (A) also stably expressing mito-mKeima were treated with OA for 6 h, then analyzed by FACS for mito-mKeima 561/488 nm ratio.(C) FACS analysis plots of HeLa cells expressing YFP-Parkin and mito-mKeima after 4 h treatment of OA or starvation showing no mitophagy detected after starvation.(D) Cells in (C) were treated with OA or OA with ULK1/2 inhibitor for 5 h followed by FACS analysis.(E) Quantification of FACS ratiometric analysis of mito-mKeima of WT or AMPK DKO U2OS cells stably expressing FKBP-GFP-ULK1, FRB-Fis1, and mito-mKeima treated with Rapalog for 24 h.(F) Quantification of FACS ratiometric analysis of mito-mKeima of HeLa cells expressing FKBP-GFP-ULK1 (WT or T180A), FRB-Fis1, and mito-mKeima treated with Rapalog for 24 h.(G) FACS analysis of mito-mKeima. HeLa cells expressing FKBP-GFP-ULK1, FRB-Fis1, and mito-mKeima were treated with Rapalog for 24 h in the presence or absence of ULK1/2 inhibitor (MRT68921, 1 μM).(H) Quantification of FACS mito-mKeima analysis of WT or AMPK DKO U2OS cells expressing FKBP-GFP-NDP52, FRB-Fis1, and mito-mKeima treated with Rapalog for 24 h.(I) WT and AMPK DKO U2OS cells expressing FKBP-GFP-FBD, FRB-Fis1, and mito-mKeima were treated with Rapalog for 8, 24, and 48 h. COXII levels were then analyzed by western blot to measure mitophagy.(J) FACS plot of mito-mKeima mitophagy analysis. Cells expressing YFP-Parkin and mito-mKeima were treated with Torin1 for 3 h.(K) Western analysis of HeLa cells expressing FKBP-GFP-FBD, FRB-Fis1, and mito-mKeima, as well as myc-mTOR. Cells were treated with Rapalog or concurrently with Torin1 (1 μM) for 24 h.(L) FACS analysis for mito-mKeima of cells expressing FKBP-GFP-FBD, FRB-Fis1, mito-mKeima, and myc-mTOR.(M) HeLa expressing FKBP-GFP-ULK1, FRB-Fis1, and myc-mTOR were analyzed for mito-mKeima signal by FACS.All FACS quantifications: n = 3 biological replicates. Data are represented as mean ± SD. p value: ^∗^ = \< 0.05; ^∗∗^ \< 0.01; ^∗∗∗^ \< 0.001; ^∗∗∗∗^ \< 0.00001; ns., not significant.See also [Figures S3](#mmc1){ref-type="supplementary-material"}, [S4](#mmc1){ref-type="supplementary-material"}, and [S7](#mmc1){ref-type="supplementary-material"}.

The lack of involvement of AMPK in PINK1/Parkin-mediated mitophagy suggests that ULK1 may autoactivate directly on cargo. In yeast, this mode of activation has been suggested for Atg1 during cytosol-to-vacuole targeting (Cvt) and pexophagy ([@bib28], [@bib51]). Targeting ULK1 kinase onto mitochondria by CID elicited mitophagy in both WT and AMPK DKO cells ([Figure 5](#fig5){ref-type="fig"}E). Introduction of a T180A mutation within the kinase loop of ULK1 completely prevented mitophagy following localization of ULK1 to the cargo ([Figure 5](#fig5){ref-type="fig"}F). This conserved threonine residue is an autophosphorylation site and is critical for ULK1 kinase activation ([@bib4]). Other ULK1 autophosphorylation sites previously identified in a screen ([@bib15]) did not affect ULK1-CID mitophagy ([Figure S4](#mmc1){ref-type="supplementary-material"}E). Treatment of cells with an ULK1/2 inhibitor completely attenuated the ULK1-CID mitophagy ([Figure 5](#fig5){ref-type="fig"}G), suggesting that, although AMPK is not required, the activation of ULK1 is necessary for cargo degradation. The absence of AMPK also did not affect mitolysosome formation induced by the tethering of NDP52 to cargo ([Figure 5](#fig5){ref-type="fig"}H). Similarly, the FIP200-binding peptide derived from ATG16L1, when localized to mitochondria of WT or AMPK DKO cells, resulted in similar levels of mitophagy ([Figures 5](#fig5){ref-type="fig"}I and [S3](#mmc1){ref-type="supplementary-material"}E). These results reveal that ULK1 localization to cargo organelles is sufficient to initiate selective autophagy even in the absence of AMPK.

mTOR phosphorylates ULK1 at S757 to inhibit its autophagic function when there is an abundance of intracellular energy ([@bib30]). We thus tested how mTOR phosphorylation of ULK1 affects its ability to initiate autophagy when tethered to cargo. Inhibition of mTOR by Torin1 does not result in mitophagy ([Figure 5](#fig5){ref-type="fig"}J), consistent with the starvation results ([Figure 5](#fig5){ref-type="fig"}C). Overexpression of mTOR increases phosphorylation of ULK1 at S757 and another established mTOR substrate, p70S6K at T389. Both phosphorylation events are eliminated in the presence of Torin1 ([Figure 5](#fig5){ref-type="fig"}K). Tethering of the FIP200-binding peptide on the mitochondria triggers mitophagy despite the sustained phosphorylation of ULK1 at S757 due to mTOR overexpression as observed by western blot ([Figure 5](#fig5){ref-type="fig"}K). Using the more sensitive mito-mKeima assay, we observed that mTOR overexpression, rather than inhibiting, slightly increased the mitolysosome formation triggered by the tethering of FIP200-binding peptide or ULK1 itself on the mitochondria ([Figures 5](#fig5){ref-type="fig"}L and 5M). These results suggest that targeting of ULK1 on cargo, and the subsequent induction of selective autophagy, can circumvent mTOR inhibition during nutrient-replete states.

TBK1 Positively Regulates Mitophagy by Facilitating NDP52-ULK1 Complex Association {#sec2.7}
----------------------------------------------------------------------------------

TBK1 phosphorylates selective autophagy receptors to increase ubiquitin binding and retention on cargo ([@bib57], [@bib21], [@bib44]). Knocking out TBK1 in HeLa or HCT116 cells decreases the mitochondrial clearance rate following up to 24 h of OA treatment ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5C) without altering the expression of ULK1 complex components ([Figure S5](#mmc1){ref-type="supplementary-material"}D). However, after 3 h of OA treatment, the mitochondrial recruitment of NDP52 in TBK1 KO cells appears to be comparable to that of WT cells ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C), suggesting an additional role for TBK1.

The mitophagy induced by tethering NDP52 onto mitochondria is attenuated in TBK1 KO cells but not in autophagy receptor KO cells, further indicating that TBK1 has functions apart from stabilizing receptors on cargo ([Figure 6](#fig6){ref-type="fig"}A). This result is consistent with previous work in xenophagy showing that TBK1 is required for the recruitment of WIPI2 ([@bib49]). On the other hand, mitochondrial localization of ULK1 fully triggered mitophagy in the absence of TBK1 or autophagy receptors, indicating that direct cargo localization of ULK1 bypasses the function of NDP52 and TBK1 ([Figure 6](#fig6){ref-type="fig"}B). The association of NDP52 and FIP200 is decreased in TBK1 KO cells, revealing that TBK1 fosters the association of NDP52 with the ULK1 complex ([Figure 6](#fig6){ref-type="fig"}C), which could partially explain why targeting of NDP52 to mitochondria in TBK1 KO cells does not elicit mitophagy. Furthermore, pharmacological inhibition of TBK1 did not block the mitophagy induced by targeting FIP200-binding peptide to the mitochondria ([Figure S3](#mmc1){ref-type="supplementary-material"}D), suggesting that TBK1 activity is specifically required for NDP52-CID mitophagy. NDP52- and ULK1-CID induced mitophagy is blocked in FIP200 KO cells, indicating that FIP200 is necessary for ULK1 activation on cargo ([Figures 6](#fig6){ref-type="fig"}A and 6B). Overexpression of WT NDP52 increased the rate of Parkin-mediated mitophagy after 3 or 6 h of OA treatment ([Figures 6](#fig6){ref-type="fig"}D and 6E). Mitophagy levels even after overexpression of NDP52 are lower in TBK1 KO cells ([Figure 6](#fig6){ref-type="fig"}D). The defect in mitophagy of TBK1 KO cells at 6 h of OA treatment is comparable to the defect in mitophagy in autophagy receptor KO cells. However, by 24 h of OA treatment, some mitophagy is detectable in TBK1 KO cells ([Figure 6](#fig6){ref-type="fig"}F), suggesting that TBK1 governs the rate of mitophagy but is not absolutely required for the process. TBK1 targeted to mitochondria induces mitophagy, whereas kinase-dead TBK1 does not ([Figure 6](#fig6){ref-type="fig"}G). Similarly, treatment with a TBK1 inhibitor prevents the induction of mitophagy after mitochondrial tethering of TBK1 ([Figure 6](#fig6){ref-type="fig"}H). Indeed, upon ectopic localization of TBK1 on mitochondria, the S172 autophosphorylation site of TBK1 can be detected on the mitochondria by immunofluorescence ([Figure S6](#mmc1){ref-type="supplementary-material"}A; box a). In Rapalog-treated cells where TBK1 failed to translocate, no phosphorylated S172 is detected ([Figure S6](#mmc1){ref-type="supplementary-material"}A, box b). In contrast, S172 phosphorylation is not observed after tethering of kinase-dead TBK1 on mitochondria ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Localizing TBK1 to mitochondria caused phosphorylation at S172 on the organelle, dependent on TBK1 kinase activity ([Figures S6](#mmc1){ref-type="supplementary-material"}C and S6D). Consistently, western blot analysis reveals an increase in S172 phosphorylation after localizing TBK1 to mitochondria ([Figure S6](#mmc1){ref-type="supplementary-material"}E). These results are consistent with biochemical and structural studies demonstrating TBK1 trans-autoactivation upon focal localization ([@bib35], [@bib20]).Figure 6TBK1 Mediates NDP52-ULK1 Complex Mitophagy(A) Quantification of FACS ratiometric analysis of mito-mKeima. WT, FIP200 KO, TKO (OPTN, NDP52 Tax1bp1 triple KO), or TBK1 KO cells stably expressing FKBP-GFP-NDP52, FRB-Fis1, and mito-mKeima treated with Rapalog for 24 h.(B) Quantification of FACS analysis of mito-mKeima. WT and KO cells as in (A), stably expressing FKBP-GFP-ULK1, FRB-Fis1, and mito-mKeima treated with 24 h Rapalog.(C) Western analysis of HA-FIP200 immunoprecipitation in WT or TBK1 KO HeLa cells. Endogenous NDP52 and TBK1 are immunoblotted.(D) FACS plots of mito-mKeima ratiometric analysis. WT or TBK1 KO cells stably expressing mito-mKeima and YFP-Parkin, and transiently expressing BFP-NDP52 were treated with OA for 3 h.(E) Western analysis. Cells stably expressing mCherry-Parkin with or without GFP-NDP52 were treated with OA for 6 h.(F) Quantification of FACS ratiometric analysis of mito-mKeima. WT, FIP200 KO, TKO, or TBK1 KO cells, all stably expressing mito-mKeima and YFP-Parkin, were treated with OA for 6 or 24 h.(G) Quantification of FACS ratiometric analysis of mito-mKeima. Cells stably expressing FRB-Fis1 and either WT FKBP-GFP-TBK1 or kinase-dead FKBP-GFP-TBK1 K38M were treated with Rapalog for 24 h.(H) mito-mKeima FACS analysis of cells stably expressing FRB-Fis1 and FKBP-TBK1 after mitochondrial localization of TBK1 with Rapalog with or without ULK1/2 inhibitor, MRT68921 at 1 μM.(I) Quantification of FACS ratiometric analysis of mito-mKeima of WT or TKO stably expressing FRB-Fis1 and WT FKBP-GFP-TBK1.(J) FACS analysis of cells expressing WT FKBP-GFP-TBK1 or FKBP-GFP-TBK1 ΔC terminus (Δ 685--729), with FRB-FIs1 and mito-mKeima after 24 h of Rapalog treatment.(K) Quantification of FACS ratiometric analysis of HeLa cells expressing FKBP-GFP-TBK1, FRB-Fis1, and mito-mKeima after 24 h of Rapalog treatment.(L) Model of NDP52/TBK1-mediated recruitment of ULK1 complex during mitophagy resulting from bypass experiments.All FACS quantifications: n = 3 biological replicates, except in (F) n = 2. Data are represented as mean ± SD. p value: ^∗^ = \< 0.05; ^∗∗^ \< 0.01; ^∗∗∗^ \< 0.001; ^∗∗∗∗^ \< 0.00001; ns., not significant.See also [Figures S5](#mmc1){ref-type="supplementary-material"}, [S6](#mmc1){ref-type="supplementary-material"}, and [S7](#mmc1){ref-type="supplementary-material"}.

The ability of TBK1-CID to initiate mitophagy is attenuated in the absence of mitophagy receptors OPTN, NDP52, and Tax1bp1, suggesting that both the kinase activity and interaction with receptor proteins are required for TBK1 to initiate mitophagy ([Figure 6](#fig6){ref-type="fig"}I). Consistently, ectopic mitochondrial placement of TBK1-ΔC terminus, which is unable to bind receptor proteins ([@bib49]), cannot trigger mitophagy ([Figure 6](#fig6){ref-type="fig"}J). Further, mitochondrially localized TBK1 is unable to induce mitophagy in the presence of ULK1/2 inhibitor, suggesting that TBK1 cargo localization causes upstream activation of ULK1 ([Figure 6](#fig6){ref-type="fig"}K). These results suggest that TBK1 modulates the ability of NDP52 to recruit and activate ULK1 on cargo by promoting NDP52-FIP200/ULK1 complex association ([Figure 6](#fig6){ref-type="fig"}L).

TBK1 Function Requires NDP52 during OA-Induced PINK1/Parkin Mitophagy {#sec2.8}
---------------------------------------------------------------------

To further test the functional relationship between NDP52 and TBK1 during PINK1/Parkin-mediated mitophagy induced by mitochondrial depolarization, we engineered various chimeric TBK1/NDP52 proteins and tested which combinations will rescue the mitophagy defect in either TBK1 KO or autophagy receptor TKO cells ([Figure S5](#mmc1){ref-type="supplementary-material"}E). WT TBK1, but not TBK1-ΔC terminus, rescues the mitophagy defect in TBK1 KO cells. However, when TBK1-ΔC terminus is fused to full-length NDP52, this chimera is now able to rescue mitophagy in TBK1 KO cells ([Figure S5](#mmc1){ref-type="supplementary-material"}F). In autophagy receptor TKO cells, TBK1-ΔC-NDP52 rescues the mitophagy defect, whereas the TBK1-ΔC-ΔSKICH-NDP52 does not ([Figure S5](#mmc1){ref-type="supplementary-material"}G), supporting the role of SKICH domain of NDP52 in associating with both TBK1 ([@bib48]) and FIP200 ([Figure 3](#fig3){ref-type="fig"}B). The ability of the TBK1-ΔC-ΔSKICH-NDP52 to rescue mitophagy in TBK1 KO cells is likely due to the presence of autophagy receptors that can compensate for the nonfunctional ΔSKICH-NDP52 ([Figure S5](#mmc1){ref-type="supplementary-material"}F).

Peroxisome Localization of NDP52 or ULK1 Induces Pexophagy {#sec2.9}
----------------------------------------------------------

We sought to determine if the ULK1 complex activation by mitochondrial targeting can be generalized to induce selective autophagic degradation of other organelles. Therefore, we localized ULK1, NDP52, and TBK1 to peroxisomes using CID by expressing FRB-PMP34 and FKBP fused to the protein of interest. We used catalase immunostaining as a measure of pexophagy. Catalase is normally a matrix-localized peroxisomal protein and thus appears in punctate structures in cells with intact peroxisomes. However, in the absence of peroxisomes, catalase mislocalizes to the cytosol and can be used as a proxy for pexophagy. Ectopic localization of NDP52 to peroxisomes resulted in peroxisomal loss, which was partially attenuated in cells lacking LC3/GABARAP proteins ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). Peroxisomes also aggregated upon localization of NDP52 to the organelle in LC3/GABARAP KO cells ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). Localizing ULK1 on peroxisomes caused their elimination, and this pexophagy was partially attenuated in LC3/GABARAP KO cells ([Figure S7](#mmc1){ref-type="supplementary-material"}C). However, similar to the mitophagy results, ULK1 was able to bypass the requirement of the five autophagy receptors when directly targeted to peroxisomes ([Figure S7](#mmc1){ref-type="supplementary-material"}C). On the other hand, consistent with our mitophagy findings, tethering TBK1 to peroxisomes of cells lacking autophagy receptor proteins did not induce pexophagy ([Figures S7](#mmc1){ref-type="supplementary-material"}D and S7E). It is important to note that overexpression of peroxisome-localized proteins could result in interference of peroxisome biogenesis, which could explain the cytosolic catalase staining partially observed even in LC3/GABARAP KO cells ([Figures S7](#mmc1){ref-type="supplementary-material"}A--S7C). Nonetheless, cytosolic catalase staining in WT cells is significantly higher than in LC3/GABARAP KO cells, indicating that pexophagy is indeed occurring after localizing NDP52 or ULK1 to peroxisomes. Expectedly, pexophagy by NDP52-CID is blocked in FIP200 KO cells ([Figure S7](#mmc1){ref-type="supplementary-material"}F). Overall, these results corroborate the mitophagy results and suggest that ULK1 cargo localization and activation can drive the process of targeted autophagy for various organelles.

Chimeric Parkin Able to Bind the ULK1 Complex Functionally Compensates for Loss of TBK1 or Receptor Proteins during Mitophagy {#sec2.10}
-----------------------------------------------------------------------------------------------------------------------------

Mitochondrial insult results in the activation of PINK1/Parkin, leading to the ubiquitination of mitochondrial outer membrane proteins. However, the chemically induced dimerization assays we utilized do not activate the PINK1/Parkin pathway and thus bypass cargo ubiquitination. To further test the model that TBK1 and NDP52 function downstream of ubiquitination pathways to recruit the ULK1 complex to cargo, we engineered a chimeric Parkin fused with an N-terminal FIP200-binding peptide (FBD-PARKIN), allowing this Parkin to associate to the ULK1 complex ([Figure 7](#fig7){ref-type="fig"}A). Cells lacking TBK1 or autophagy receptor proteins are defective in mitophagy after 6 h of OA treatment ([Figure 6](#fig6){ref-type="fig"}F). Stable expression of FBD-Parkin in either of these KO cells can rescue the mitophagy defect, bypassing the function of NDP52/TBK1 in recruiting the ULK1 complex during depolarization-induced mitophagy ([Figure 7](#fig7){ref-type="fig"}B). As a control, we fused an FBD mutant unable to bind FIP200 (E230R/E241R) to Parkin. This chimera initiates mitophagy in WT cells, due to the functional Parkin, but fails to rescue the mitophagy deficiency in either TBK1 or receptor KO cells ([Figure 7](#fig7){ref-type="fig"}C). Further, fusing FBD to a Parkin mutant defective in mitochondrial translocation (K211N; [@bib32]) also fails to rescue mitophagy in WT and KO cells ([Figure 7](#fig7){ref-type="fig"}D). These data further demonstrate that a critical function of TBK1 and NDP52 is to target the ULK1 complex to ubiquitinated cargo. The incomplete rescue of FBD-Parkin observed particularly in receptor 5KO cells, however, suggests that receptor proteins may have other functions apart from recruiting the ULK1 complex.Figure 7Chimeric FBD-Parkin Can Compensate for Loss of TBK1 or Receptor Proteins during Mitophagy(A) Model for the bypass experiment performed using FIP200-binding peptide-Parkin (FBD-Parkin) in WT, TBK1 KO, or 5KO (OPTN, NDP52, Tax1bp1, NBR1, p62) cells.(B) Mitophagy analysis by FACS. WT HeLa cells, TBK1 KO, or 5KO cells expressing mito-mKeima and FBD-Parkin.(C and D) (C) FBD-Parkin (E230R/E241R) or (D) FBD-Parkin (K211N) were treated with OA and QVD for 6 h.All FACS quantifications: n = 3 biological replicates. Data are represented as mean ± SD. p value: ^∗^ = \< 0.05; ^∗∗^ \< 0.01; ^∗∗∗^ \< 0.001; ^∗∗∗∗^ \< 0.00001; ns., not significant.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

The basis for cargo discrimination during selective autophagy often highlights the role of autophagy receptor proteins, such as NDP52, and their ability to target preformed phagophores to cargo by binding LC3 ([@bib31], [@bib8]). However, this model does not address how a cell can concomitantly increase the formation of phagophores when demand for selective autophagy increases. In order to increase autophagy flux and generate more phagophores, ULK1 kinase activity is upregulated ([@bib36]). However, ULK1 is constitutively repressed by energy sensors, such as mTOR, during energy-replete cellular states ([@bib22], [@bib40], [@bib30]). How ULK1 activity is amplified to overcome repression under nutrient-rich conditions to adapt to selective autophagy demands is unknown. Seminal work in yeast revealed that Atg1, the yeast ortholog of ULK1, can be locally activated at the vacuole during Cvt, where the presence of both cargo and receptor protein Atg19 is required for Atg1 activity ([@bib28], [@bib51]). In agreement with this model, we found that ectopically localizing ULK1 to mitochondria or peroxisomes is sufficient to activate it and induce organelle degradation. AMPK is not required for ULK1 activation when ULK1 is targeted to cargo organelles, in distinction from starvation-induced macroautophagy. In addition, ULK1 autophosphorylation occurs independently of AMPK ([@bib4]). We also found that mTOR phosphorylation of ULK1 had a minimal effect on cargo degradation when the ULK1 complex is tethered to cargo. A possible mechanism for ULK1 autoactivation is by homo-oligomerization, as reported for other kinases ([@bib16], [@bib20]). Indeed, Atg1 activity is controlled by its local clustering ([@bib51]), consistent with our conclusion that increasing the local concentration of ULK1 on cargo is sufficient to drive autophagic induction, overcoming the repression of autophagy under nutrient-rich conditions.

Experimental tethering of NDP52 on mitochondria and peroxisomes promoted their elimination and depended on the association of NDP52 with the ULK1 complex via FIP200. Furthermore, rescue experiments in receptor knockout cell lines revealed that the LC3-binding capacity of NDP52 is dispensable for its function during mitophagy. Thus, it is likely that NDP52, rather than recruiting preformed phagophores to cargo, instead targets the ULK1 complex to initiate autophagosome biogenesis directly on the cargo. This interpretation is consistent with recent studies showing that cargo receptors are important for the recruitment of the ULK1 complex, as well as other downstream ATG machinery, during mitophagy ([@bib34]) and that LC3/GABARAP proteins are dispensable for proper targeting of autophagosomes but are instead important for autophagosome fusion with lysosomes ([@bib38], [@bib42]). In neurons, LC3 foci appear in distal axons only after induction of Parkin-mediated mitophagy. Before triggering mitophagy, LC3 foci were not detected along axons, consistent with the model that autophagosomes are generated on demand during selective autophagy ([@bib3]). Nevertheless, it is evident that LC3/GABARAP proteins fulfill an essential role for proper maturation of autophagosomes, since mitophagosomes expanded more slowly and are smaller in diameter in LC3/GABARAP KO cells ([@bib38]). LIR-binding domains are present or are predicted to be present among many ATG and ATG-related proteins ([@bib1], [@bib33], [@bib27]). This might conceivably be how LC3 proteins mediate phagophore expansion during selective autophagy. Furthermore, it is highly likely that other receptors, such as OPTN, Tax1bp1, NBR1, and p62, may have activities overlapping with those of NDP52 in targeting upstream ATG components, apart from LC3, to various organelles during selective autophagy.

It is worth noting that the degree of mitophagy achieved by tethering single proteins on mitochondria is low in comparison to that caused by depolarizing agents. This is likely because the chemically induced dimerization experiments do not activate Parkin, while mitochondrial depolarizers do. Parkin ubiquitination of outer mitochondrial membrane (OMM) proteins is critical for the downstream recruitment of proteins that positively regulate mitophagy. For example, p97/VCP is recruited to mitochondria after Parkin activation to degrade Parkin-ubiquitinated OMM proteins ([@bib47]). This OMM remodeling event is important for efficient mitophagy. Parkin recruits other factors, such as RABGEF1, that likely accelerate the mitophagosome membrane assembly ([@bib59]). Thus, other molecular events that depend on Parkin are missing in our experimental setup, possibly decreasing the total efficiency of mitophagy.

NDP52 concentrates the ULK1 complex on ubiquitinated cargo by binding FIP200. ATG16L1 also interacts with FIP200, suggesting that ATG16L1 may promote crosstalk between the later-stage LC3 lipidation pathway with the more-upstream ULK1 complex ([@bib17], [@bib39]). We were able to experimentally validate our findings with NDP52 using a FIP200-binding peptide derived from ATG16L1 that mimics NDP52 recruitment and activation of ULK1 on cargo. Pharmacologic inhibition of ULK1 completely attenuates mitophagy caused by ectopic localization of NDP52, the ATG16L1 peptide, or ULK1 itself to mitochondria, whereas loss of AMPK or overexpression of mTOR did not affect mitophagy induced by dimerization of these proteins to cargo. These findings corroborate the model that NDP52 induces ULK1 activation directly on the cargo.

TBK1 increases the affinity of receptor proteins to ubiquitin chains on cargo, leading to their increased retention on cargo ([@bib21], [@bib44]). However, TBK1 may encompass a broader role in autophagosome biogenesis ([@bib49], [@bib41]). Indeed, our experiments indicate that TBK1 functions in promoting the association of NDP52 with FIP200, possibly through the phosphorylation of NDP52, a known TBK1 substrate. However, inhibition of TBK1 did not affect the mitophagy induced by the FIP200-binding peptide, suggesting that TBK1 selectively mediates the interaction between NDP52 and FIP200. Interestingly, localizing TBK1 to mitochondria and peroxisomes induces the degradation of the respective organelles, which requires TBK1 kinase activity. Mitochondrial and peroxisomal localization of TBK1 did not trigger clearance of either organelle in cells lacking autophagy receptors, suggesting that TBK1 function during autophagy occurs via the autophagy receptors. Structural studies show that receptor-mediated focal localization sufficiently activates TBK1 through trans-autophosphorylation ([@bib35], [@bib20]). Thus, the activation mechanisms of TBK1 and ULK1 may share the common feature of proximity-induced activation. Here, we provide evidence that the localization of the ULK1 complex by NDP52 and TBK1 on cargo couples the activation and spatial regulation of ULK1 independently of AMPK and mTOR. This model simultaneously resolves the timing and positioning of selective autophagy induction.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**ActinCST (Cell Signaling Technology)4967SAMPK alpha1/2CST2532S; RRID:[AB_10694064](nif-antibody:AB_10694064){#interref25}ATG13MBLM183-3ATG14Proteintech19491-1-AP; RRID:[AB_10642701](nif-antibody:AB_10642701){#interref30}CatalaseAbcamab16731COXIIAbcamab110258; RRID:[AB_10887758](nif-antibody:AB_10887758){#interref35}FIP200Proteintech17250-1-AP; RRID:[AB_10666428](nif-antibody:AB_10666428){#interref40}FlagSigma AldrichF3165GapdhSigma-AldrichG9545; RRID:[AB_796208](nif-antibody:AB_796208){#interref45}GFPDSHBGFP-1D2HACST3724SLC3BCST2775S; RRID:[AB_915950](nif-antibody:AB_915950){#interref50}MycCST9405sNDP52CSTD1E4A;RRID:[AB_2732810](nif-antibody:AB_2732810){#interref55}NDP52Sigma AldrichSAB1406957; RRID:[AB_10741310](nif-antibody:AB_10741310){#interref60}p62AbnovaH00008878-M01; RRID:[AB_437085](nif-antibody:AB_437085){#interref65}p70S6KCST2708Pp70S6K T389CST9205ParkinSanta CruzPRK8; RRID:[AB_628104](nif-antibody:AB_628104){#interref70}TBK1CSTD1B4; RRID:[AB_2255663](nif-antibody:AB_2255663){#interref75}TBK1 S172CST5483S; RRID:[AB_10693472](nif-antibody:AB_10693472){#interref80}TBK1 S172AbcamEPR2867(2)Tim23Santa CruzT-20Tom20Santa CruzFL145 (Rabbit) / F-10 (Mouse)ULK1CSTD8H5; RRID:[AB_11178668](nif-antibody:AB_11178668){#interref85}ULK1 pS757CST6888SAlexa Fluor 405 goat anti-rabbit IgG (H+L)ThermofisherA31556Alexa Fluor 488 goat anti-rabbit IgG (H+L)ThermofisherA11008Alexa Fluor 546 goat anti-rabbit IgG (H+L)ThermofisherA11035Alexa Fluor 594 goat anti-rabbit IgG (H+L)ThermofisherA11012Alexa Fluor 633 goat anti-rabbit IgG (H+L)ThermofisherA21071Alexa Fluor 647 goat anti-rabbit IgG (H+L)ThermofisherA21244Alexa Fluor 488 goat anti-mouse IgG (H+L)ThermofisherA21202Alexa Fluor 546 goat anti-mouse IgG (H+L)ThermofisherA11003Alexa Fluor 594 goat anti-mouse IgG (H+L)ThermofisherA11005Alexa Fluor 633 goat anti-mouse IgG (H+L)ThermofisherA21052Alexa Fluor 647 goat anti-mouse IgG (H+L)ThermofisherA21235**Chemicals, Peptides, and Recombinant Proteins**A/C heterodimerizer (Rapalog)Takara635057antimycin ASigma-AldrichA8674BafilomycinSigma-AldrichB1793DAPIThermofisher62248DRAQ7CST7406SDSP(dithiobis(succinimidyl propionate))Thermofisher22585MRT67307, TBK1 inhibitorSelleckchemS7948MRT68921, ULK1 inhibitorSelleckchemS7949OligomycinCalBiochem495455PolybreneSigma-AldrichH9268Q-VDApexBioA1901ValinomycinSigma-AldrichV0627FuGENE HDPromegaE231AOmni-AvalanceEZ BiosystemEZT-OMNI-1DMEMThermofisher31053028McCoy's 5AThermofisher16600082Sodium pyruvateThermofisher11360070GlutaMaxThermofisher35050061Nonessential amino acidsThermofisher11140050HEPESThermofisher15630080Opti-MEMThermofisher319850620.05% Trypsin-EDTAThermofisher25300054BamBankerWako302-14681DTTSigma-AldichD0632HBSS with calcium and magnesiumThermofisher14025-092paraformaldehyde 16% solution, EM gradeElectron Microscopy Sciences15710polyethylenimine, linear, MW 25000, transfection grade, (PEI 25K)PolySciences23966-1PhosSTOPRoche4906845001Protease inhibitor cocktailRoche11873580001puromycinInvivogenant-pr-1**Experimental Models: Cell Lines**U2OS WT[@bib52]N/AAMPK DKO U2OS[@bib52]N/AFIP200 KO HeLaThis studyN/ATBK1 KO HeLa[@bib34]N/AOPTN/NDP52/Taxbp1 TKO HeLa[@bib34]N/APink1 KO HeLa[@bib29]N/AATG8 6KO HeLa[@bib38]N/AOPTN/NDP52/Taxbp1/p62/NBR1 5KO HeLa[@bib34]N/AHeLaATCCCCL-2.2293TATCCCRL-3216HCT116ATCCCCL-247TBK1 KO HCT116This study; CRISPR sgRNA used in [@bib34]N/Amt-mKeima/YFP-Parkin stable HeLa[@bib34]N/AmCherry-Parkin stable HeLa[@bib34]N/A**Oligonucleotides**FIP200-e4-5′ crisprGCTATGTAAAAACACCTTAGN/AFIP200-e4-3′ crisprGTAGTTTTAGGAATAGCAGGN/AFIP200-e4-CEL1-FAGACCTGATAACCAGTTTGAGCATPCR product 799 bp. 435 bp deletion with CRISPRFIP200-e4-CEL1-RTGTCAAACTTTTTGCATACTTCCTN/A**Recombinant DNA**p3xFLAG-CMV-hATG13Addgene22872p3xFLAG-CMV10-hFIP200Addgene24300p3XFLAG-CMV10-mApg16LAddgene24302pBMN-FKBP-mEGFP-ATG14This studyN/ApBMN-FKBP-mEGFP-ATG16L1This studyN/ApBMN-FKBP-mEGFP-ATG16L1FBDThis studyN/ApBMN-FKBP-mEGFP-ATG16L1FBD_E230R_E241RThis studyN/ApBMN-FKBP-mEGFP-mULK1This studyN/ApBMN-FKBP-mEGFP-mULK1_T180AThis studyN/ApBMN-FKBP-mEGFP-NDP52This studyN/ApBMN-FKBP-mEGFP-NDP52_C425AThis studyN/ApBMN-FKBP-mEGFP-TBK1This studyN/ApBMN-FKBP-mEGFP-TBK1_K38MThis studyN/ApBMN-mCherry-Parkin[@bib34]N/ApBMN-mCherry-Parkin[@bib34]N/ApBMN-mEGFP-NDP52[@bib34]N/ApBMN-puro-P2A-FRB-Fis1[@bib34]N/ApBMN-YFP-Parkin[@bib34]N/ApC4-RhE-PMP34-FRB[@bib34]N/ApcDNA3-Flag-ULK1Addgene27636pcDNA6.2-Myc-ULK1Addgene27629pCHAC-mt-mKeima[@bib34]N/ApHAGE-FKBP-FLAG-HA-NDP52This studyN/ApHAGE-FKBP-FLAG-HA-TBK1This studyN/ApHAGE-FKBP-FLAG-HA-ULK1This studyN/ApHAGE-FKBP-GFP-ULK1This studyN/ApHAGE-FKBP-GFP-ULK1_S1042AThis studyN/ApHAGE-FKBP-GFP-ULK1_S1047AThis studyN/ApHAGE-FKBP-mEGFP-OPTNThis studyN/ApHAGE-FKBP-mEGFP-TBK1This studyN/ApHAGE-FKBP-mEGFP-TBK1_dCThis studyN/ApHAGE-FKBP-mEGFP-TBK1_dC-NDP52This studyN/ApHAGE-FKBP-mEGFP-TBK1_dC-NDP52_dSkichThis studyN/ApHAGE-FKBP-mEGFP-TBK1_K38MThis studyN/ApCR3-3XFlag-NDP52[@bib53]N/ApCR3-3XFlag-NDP52 dSKICH-dCLIR[@bib53]N/ApCR3-3XFlag-NDP52 C425A[@bib53]N/ApHAGE-FLAG-HA-NDP52[@bib34]N/ApHAGE-FLAG-HA-NDP52This studyN/ApHAGE-FLAG-HA-NDP52_C425AThis studyN/ApHAGE-FLAG-HA-NDP52_dSkich_dCLIRThis studyN/ApHAGE-FLAG-HA-NDP52_dSkich_dCLIR_C425AThis studyN/ApHAGE-FLAG-HA-NDP52_dSkich_dCLIR_LIR-nullThis studyN/ApHAGE-FLAG-HA-NDP52_LIR-like-nullThis studyN/ApHAGE-GFP-FBD_EE-ParkinThis studyN/ApHAGE-GFP-FBD-ParkinThis studyN/ApHAGE-GFP-FBD-Parkin_K211NThis studyN/ApHAGE-mt-mKeima-P2A-FRB-Fis1This studyN/ApHAGE-mTagBFP2-NDP52This studyN/ApME18s-HA-hFIP200Addgene24303pMEs-3xHA-FIP200_C1This studyN/ApMEs-3xHA-FIP200_C2This studyN/ApMEs-3xHA-FIP200_C3This studyN/ApMEs-3xHA-FIP200_LZ onlyThis studyN/ApMEs-3xHA-FIP200_LZ7AThis studyN/ApMEs-3xHA-FIP200_LZ7A onlyThis studyN/ApMEs-3xHA-FIP200_N1This studyN/ApMEs-3xHA-FIP200_Q4AThis studyN/ApMXs-IP-EGFP-hFIP200Addgene38192pMXs-IP-EGFP-ULK1Addgene38193pMXs-IP-Venus-mULK1Addgene58743pMXs-puro-GFP-DFCP1Addgene38269pMXs-puro HA-ATG14Addgene22877pRK5-Myc-mTORAddgene1861**Others**Amersham ECL Prime WB detection reagentGE Healthcare Life SciencesRPN2232SuperSignal West Femto Luminol/Enhancer solutionThermofisher1859022SuperSignal West Femto stable peroxide bufferThermofisher1859023NEBuilderHiFi DNA assembly master mixNew England BioLabsM5520AQ5 Hot Start High-Fidelity DNA PolymeraseNew England BioLabsM0493LPhusion Hot Start II DNA polymeraseThermofisherF-549LDNA Ligation kit, Mighty MixTakara[6023](mi:6023){#intref0010}LDS sample buffer (4x)ThermofisherNP0007GFP-TRAP magnetic beadsChromotekgtma-20FLAG-beadsSigma-AldrichM8823Triton X-100Sigma-AldrichT9284Tween-20Sigma-AldrichP79493xFLAG peptideThermofisherA36806Protein A/G magnetic beadsThermofisher88802HA BeadsThermofisherN/A**Software and Algorithms**MATLABN/AImageJN/APrismN/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Richard Youle (<youler@ninds.nih.gov>)

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell Lines {#sec4.3.1}

HEK293T, HeLa and HCT116 cells were purchased from ATCC. HEK293T, U2OS and HeLa cells were cultured in Dulbecco's modified eagle medium (DMEM) with 10% (v/v) Fetal Bovine Serum (FBS) (Gemini Bio and Sigma), 1 mM Sodium Pyruvate, 1x nonessential amino acids (NEAA), 2 mM GlutaMAX, and 10 mM Hepes. HCT116 cells were cultured in McCoy's 5A medium with 10% FBS, 2 mM GlutaMax and 1x NEAA. WT and AMPK alpha ½ double KO U2OS (DKO, gifts from Dr. Reuben Shaw, Salk Institute, San Diego) were cultured in the same manner. All media and supplements were from Thermo Fisher. All cells were tested for mycoplasma contamination every two weeks with PlasmoTest kit (InvivoGen). Reagents used for transfections were Avalanche-OMNI (EZ Bio-Systems), X-tremeGENE 9 (Roche), FuGeneHD (Promega) or Polyethylenimine (PEI) (PolySciences). The full list of antibodies and reagents are found in Key Resources Table.

Method Details {#sec4.4}
--------------

### Knock out line generation using CRISPR/Cas9 gene editing {#sec4.4.1}

CRISPR gRNAs were generated to target common exons of FIP200 shared by all splice variants. Two gRNAs (ACTATGTAAAAACACCTTAG and GTAGTTTTAGGAATAGCAGG) were used to delete the entire frame-shifting exon 4 and exon 5 of FIP200. gRNAs were cloned into pSpCas9(BB)-2A-Puro (PX459) V2.0 (Addgene plasmid \#62988). To Make FIP200 KO, HeLa cells were transfected with the two gRNA plasmids and treated with 1 ug/ml puromycin for 2 days to enrich transfected cells, which were then diluted and placed into 96-well plates for single colonies. Primer set (AGACCTGATAACCAGTTTGAGCAT and TGTCAAACTTTTTGCATACTTCCT) were used for PCR screening of FIP200 KO clones. TBK1 gRNA was previously reported ([@bib34]) and used to make HCT116 TBK1 KO cells following similar protocol ([@bib34]).

### Cloning and stable cell line generation {#sec4.4.2}

For retroviral and lentiviral constructs, inserts were either amplified by PCR or synthesized (Thermo Fisher) and cloned into pBMN-Z vector or pHAGE vector, respectively by Gibson assembly (New England Labs) or Gateway cloning (Thermo Fisher). Deletion mutants were generated using Gibson Cloning. Point mutants were generated by site directed mutagenesis. All constructs used or generated in this study were validated by Sanger sequencing and complete plasmid sequences and maps are available upon request.

Stable expression of retroviral and lentiviral constructs in HeLa cells were achieved as follows: retroviruses and lentiviruses were packaged in HEK293T cells by transfecting constructs together with appropriate helper plasmids and PEI. The next day, fresh media were added. Viruses were harvested 48 hrs and 72 hrs after transfection and transduced in HeLa cells with 8 μg/mL polybrene (Sigma). Cells were then directly used in experiments or optimized for expression by FACS.

### Western Analyses {#sec4.4.3}

Cells seeded into 6-well or 12-well plates were washed with phosphate buffered saline (PBS) and lysed with LDS sample buffer (Thermo Fisher) with 50 mM dithiothreitol (DTT, Sigma). Samples were boiled at 99°C for 10 min. 20-50 μg of protein lysate of each sample was loaded and separated on 4-12% Bis-Tris gels (Thermo Fisher) according to manufacturer's protocol. Gels were transferred to polyvinyl difluoride membranes and immunostained using specific antibodies. For mitophagy measurements by immunoblotting, cells were treated with 10 μM Oligomycin (Calbiochem), 10 μM Antimycin A (Sigma) and 10 μM QVD (ApexBio) in growth medium at different timepoints indicated in figure legends, prior to western blot analysis. For mitophagy measurements after ectopic protein localization to mitochondria, cells were treated with A/C heterodimerizer Rapalog (Clonetech) for various periods, indicated in figure legends, prior to western blot analysis.

### Immunoprecipitation, GFP-TRAP, HA and Flag beads precipitation {#sec4.4.4}

For GFP-TRAP (Chromotek), HA-beads (Pierce), Flag-beads (Sigma-Aldrich) precipitation experiments, HEK293T cells seeded in 6-well plates were co-transfected with specific constructs to overexpress proteins of interest for 24 to 48 h. Cells were then lysed using ice cold lysis buffer (150 mM Tris-buffered Saline, 50 mM NaCl, with 0.5% v/v Triton-X 100) supplemented with EDTA-free cOmplete protease inhibitor (Roche). Samples were incubated on ice with intermittent agitation by pipetting for 30 min. Beads were equilibrated using bead resuspension buffer (150 mM Tris-buffered Saline, 50 mM NaCl, 0.25% Tween). Protein lysates were precleared by centrifugation at 4°C for 10 min at 15,000 g. Clarified lysates were incubated with specific equilibrated beads for various periods at 4°C. Beads were then washed with ice cold Wash buffer (150 mM Tris-buffered Saline, 50 mM NaCl) 3 to 5 times. Bound proteins were eluted with LDS lysis buffer (Thermo Fisher) with 50 mM DTT. GFP-TRAP proteins were eluted in boiling conditions while HA-bead bound proteins were eluted at 37°C for 10 min. Flag-bead bound proteins were eluted by competition using 3X Flag (Pierce) as recommended by the manufacturer. Beads were then separated from eluent. GFP-TRAP eluent samples were boiled for an additional 10 min. Samples were processed for immunoblotting as described in the western blot analyses section.

For endogenous immunoprecipitation, cells were lysed in lysis buffer and clarified, as shown above. Clarified lysates were first incubated with antibodies specified in figure legends for 24 h at 4°C. A/G beads (Pierce) were equilibrated with resuspension buffer then incubated with antibody-lysate mix for 1 h at 4°C. Beads were washed as above. Bound samples were eluted using LDS lysis buffer with 50 μM DTT at 37°C. Samples were processed for immunoblotting as above. However, to reduce denatured IgG background bands, TrueBlot (Rockland) secondary antibodies were used. In some experiments, 200 nM of Bafilomycin (Selleckchem) was used for various periods.

### Immunofluorescence microscopy {#sec4.4.5}

Cells seeded in 2-well or 4-well chamber slides (Lab-Tek) were treated as indicated in figure legends. After treatment, cells were rinsed in PBS and fixed with 4% paraformaldehyde at RT for 10 min. Cells were washed with PBS. For immunostaining, cells were then permeabilzed and blocked with 0.1% Triton X-100, 3% goat serum in TBS or PBS for 15 min at RT. After, cells were incubated with 0.1% Triton X-100, 3% goat serum in TBS or PBS supplemented with antibodies (1:1000) overnight at 4°C. Cells were then washed with PBS 3 times and incubated with Alexa 488 or 546, 633-conjugated secondary antibodies (Thermo Fisher). For cells expressing fluorescent tagged proteins, cells were seeded as above. After treatments, cells were fixed as above and washed 3 times with PBS prior to image analysis. For live imaging of mito-mKeima of cells in [Figure 1](#fig1){ref-type="fig"}B, live cells in 2-chamber slides were treated with Rapalog for 24 h, placed in a CO2 chamber platform of LSM 880 at 37°C. Images were taken using a 20x air, 63x oil, or 40x oil DIC objective on an LSM 510 or 880 microscope (Zeiss).

### Image Analysis {#sec4.4.6}

To quantify colocalization, Pearson's correlation coefficients were quantified with a custom MATLAB script. Briefly, images were background subtracted then cells segmented from background by intensity and size prior to pixel-by-pixel correlation. Tile images were used to increase the number of cells quantified, then different sites of the chamber slide were used to find the average and error for the experiment. P values were determined with an unpaired Student's T-test from different sites. We also generated custom MATLAB scripts for automated puncta counting. The images were background subtracted then several binary masks created to find puncta of interest including a mask for cells positive for transfection, a mask for mitochondria using a TOM20 stain, a mask for FKBP-GFP positive subcellular location, and a mask for puncta. The puncta mask was made by passing the background subtracted image through Gaussian filters then dividing the image by those filters to accentuate regions of high contrast. Two-dimensional maxima were found across the image, filtered by size, then filtered by all masks to find legitimate protein puncta amid noise and highly transfected cells. Puncta were then counted and divided by the number of positive cells, distinguished and segmented with a nuclear dye.

### Mitochondrial recruitment of proteins during Parkin-mediated mitophagy {#sec4.4.7}

Cells stably expressing or transiently expressing constructs, as specified in figure legends were seeded in 2-well or 4-well chambers (Lab-Tek). Cells were treated with 10 μM Oligomycin (Calbiochem), 10 μM Antimycin A (Sigma) and 20 μM QVD (ApexBio). Cells were simultaneously treated with 200 nM Bafilomycin to prevent degradation of proteins of receptor and ATG proteins.

### Chemically inducible dimerization assays {#sec4.4.8}

For mitochondrial localization of NDP52, ULK1, FIP200-binding peptide (FBD) and TBK1, 2XFKBP was fused to GFP-Tagged NDP52, ULK1, FBD, or TBK1 in pBMN retroviral or pHAGE lentiviral vector. For mitochondrial recruitment assays, cells stably expressing specific FKBP construct with FRB-Fis1 and mito-mKeima (previously described by [@bib34]) were treated with 0.5 μM A/C heterodimerizer (simply named as Rapalog in the text) (Clontech) for 24 h. Cells were either imaged live or fixed and immunostained as described above.

### Mitophagy assay with mito-mKeima via fluorescence activated cytometer {#sec4.4.9}

Stable cell lines were generated to express mito-mKeima, FRB-Fis1 or FRB-mTagBFP2-Fis1, and FKBP-GFP-tagged target genes with retrovirus or lentivirus system. 100K cells were seeded in 12-well plates and treated with Rapalog for 24h or by OA at various time points before FACS analysis. FACS analysis were performed as previously described ([@bib34]).

### Pexophagy assay {#sec4.4.10}

About 50-100K HeLa cells were seeded in 2-well chamber slides (Labtek) and transfected with 0.2 ug of mito-GFP, 0.6 ug of FRB-PMP34 and 0.4 ug of FKBP-FLAG-HA-NDP52 or 0.8 ug of FKBP-FLAG-HA-TBK1 with 1:3 ratio of FuGeneHD (Progemga). 18hr after transfection, cells were treated with Rapalog for 30h or 48h, fixed and immunostained with anti-HA (Cell Signaling) and anti-catalase (CalBiochem).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

All statistical analyses for FACS were calculated in GraphPad Prism 6. Statistical significance was assessed from three independent experiments using one-way or two-way ANOVA with a confidence interval of 95%. Error bars are expressed as mean ± standard deviation.
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